Catalyst Pharmaceuticals, Inc. [CPRX]

Source: 

Company Overview

Catalyst Pharmaceuticals, Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. We currently market three drug products, FIRDAPSE   (amifampridine), FYCOMPA   (perampanel), and AGAMREE   (vamorolone).